• HOME
  •  > 
  • 薬学
  •  > 
  • 雑誌
  •  >  医学と薬学　76/12　2019年12月号

医学と薬学　76/12　2019年12月号

出版社： 自然科学社
発行日： 2019-11-27
分野： 薬学  >  雑誌
ISSN： 03893898
雑誌名：
特集： 睡眠障害治療の最前線
電子書籍版： 2019-11-27 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,540 円(税込)

購入する

目次

  • 特集　睡眠障害治療の最前線

    序文
    不眠症治療の適正化を考える
    レストレスレッグス症候群の病態と治療
    閉塞性睡眠時無呼吸症治療の最近の進歩
    REM睡眠行動障害とαシヌクレイノパチーとの関連性について
    概日リズム睡眠―覚醒障害（睡眠-覚醒相後退障害）の病態と治療
    ナルコレプシーの病態と治療

    臨床試験
    　ラバミコム®配合錠「アメル」の生物学的同等性試験

    Diagnosis
    　ロイシンリッチα2グリコプロテイン測定試薬「ナノピアLRG」の開発と性能検討
    　RSウイルス抗原迅速診断キット「クイックナビ™-RSV2」の評価
    「BioPlex MMRV IgGキット」の性能評価
    　免疫発光測定装置 ルミパルスL2400を用いた新規可溶性インターロイキン-2レセプター測定試薬
    　 「ルミパルスプレストIL-2R」の基礎性能評価
    　ルミパルスL2400に搭載する新規SCC抗原測定試薬の基礎的検討
    　サンドイッチ法によるCLEIAを原理とした血清，血漿および尿中アルドステロン測定試薬
    　 （ルミパルスプレストアルドステロン）の基礎的検討
    　CLEIAを原理とした血清，血漿中レニン測定試薬（ルミパルスプレストレニン）の基礎的検討
    　発熱後経過時間とインフルエンザウイルス量の相関性についての一知見
    　　―インフルエンザ迅速診断キット（5分判定法）の臨床評価―

    Health Care
    　ZERO-G TOUCHの施術が肩および腰に与える影響に関する検証試験

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【特集 睡眠障害治療の最前線】

P.1702 掲載の参考文献
1) Murakoshi A, Takaesu Y, Komada Y et al : Prevalence and associated factors of hypnotics dependence among Japanese outpatients with psychiatric disorders. Psychiatry Res 230 (3) : 958-963, 2015.
PubMed
2) Stewart SA : The effects of benzodiazepines on cognition. J Clin Psychiatry 66 (Suppl 2) : 9-13, 2005.
 
3) Wang PS, Bohn RL, Glynn RJ et al : Hazardous benzodiazepine regimens in the elderly : effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 158 (6) : 892-898, 2001.
PubMed
4) 三島和夫 (睡眠薬適正使用及び減量・中止のための診療ガイドラインに関する研究班) 編 : 睡眠薬の適正使用・休薬ガイドライン, じほう, 東京, 2014.
 
5) Kon AA : The shared decision-making continuum. JAMA 304 (8) : 903-904, 2010.
PubMed
6) Qaseem A, Kansagara D , F orciea MA e t al : Management of Chronic Insomnia Disorder in Adults : A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 165 (2) : 125-133, 2016.
 
7) 内山真, 内村直尚, 井上雄一 : 一般診療における不眠マネジメントに関するコンセンサス・レポート. ねむりと医療 3 : 45-66, 2010.
 
8) van der Hooft CS, Schoofs MW, Ziere G et al : Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 66 (2) : 276-282, 2008.
PubMed
9) Thomas RE : Benzodiazepine use and motor vehicle accidents. Can Fam Physician 44 : 790-808, 1998.
 
10) Lugoboni F, Quaglio G : Exploring the dark side of the moon : the treatment of benzodiazepine tolerance. Br J Clin Pharmacol 77 (2) : 239-241, 2014.
PubMed
11) Lader M : Benzodiazepine Harm : How Can It Be Reduced? Br J Clin Pharmacol 77 (2) : 295-301, 2014.
PubMed
12) Pandi-Perumal SR, Srinivasan V, Spence DW et al : Ramelteon: a review of its therapeutic potential in sleep disorders. Adv Ther 26 (6) : 613-626, 2009.
PubMed
13) Sateia MJ, Buysse DJ, Krystal AD et al : Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults : An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 13 (2) : 307-349, 2017.
PubMed
14) Schroeck JL, Ford J, Conway EL et al : Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clin Ther 38 (11) : 2340-2372, 2016.
PubMed
15) Hatta K, Kishi Y, Wada K et al : Preventive effects of ramelteon on delirium : a randomized placebo-controlled trial. JAMA Psychiatry 71 (4) : 397-403, 2014.
PubMed
16) Dubey AK, Handu SS, Mediratta PK : Suvorexant : The first orexin receptor antagonist to treat insomnia. J Pharmacol Pharmacother 6 (2) : 118-121, 2015.
PubMed
17) Azuma K, Takaesu Y, Soeda H et al : Ability of suvorexant to prevent delirium in patients in the intensive care unit : a randomized controlled trial. Acute Med Surg 5 (4) : 362-368, 2018.
PubMed
18) Hatta K, Kishi Y, Wada K et al : Preventive Effects of Suvorexant on Delirium : A Randomized Placebo-Controlled Trial. J Clin Psychiatry 78 (8) : e970-e979, 2017.
 
19) Luyster FS, Buysse DJ, Strollo PJ, Jr : Comorbid insomnia and obstructive sleep apnea : challenges for clinical practice and research. J Clin Sleep Med 6 (2) : 196-204, 2010.
 
20) Marshall NS, Yee BJ, Desai AV et al : Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Sleep 31 (6) : 824-831, 2008.
PubMed
21) Markkula J, Lauerma H : Mianserin and restless legs. Int Clin Psychopharmacol 12 (1) : 53-58, 1997.
PubMed
22) Yang C, White DP, Winkelman JW : Antidepressants and periodic leg movements of sleep. Biol Psychiatry 58 (6) : 510-514, 2005.
PubMed
23) Winkelman JW : CLINICAL PRACTICE. Insomnia Disorder. N Engl J Med 373 (15) : 1437-1444, 2015.
PubMed
24) Morin CM, Colecchi C, Stone J et al : Behavioral and pharmacological therapies for late-life insomnia : a randomized controlled trial. JAMA 281 (11) : 991-999, 1999.
PubMed
25) Okajima I, Nakamura M, Nishida S et al : Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia. Psychiatry Res 210 (2) : 515-521, 2013.
PubMed
26) 高江洲義和 : 鎮静系抗うつ薬. ねむりとマネージメント 4 (1) : 24-7, 2017.
Medical*Online
27) Belleville G, Guay C, Guay B et al : Hypnotic taper with or without self-help treatment of insomnia : a randomized clinical trial. J Consult Clin Psychol 75 (2) : 325-335, 2007.
PubMed
28) Lichstein KL, Nau SD, Wilson NM et al : Psychological treatment of hypnotic-dependent insomnia in a primarily older adult sample. Behav Res Ther 51 (12) : 787-796, 2013.
 
29) Takaesu Y, Utsumi T, Okajima I et al : Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia : A systematic review and meta-analysis. Sleep Med Rev 48 : 101214, 2019.
PubMed
P.1712 掲載の参考文献
1) Allen RP, Walters AS, Montplaisir J et al : Restless legs syndrome prevalence and impact : REST general population study. Arch Intern Med 165 (11) : 1286-1292, 2005.
PubMed
2) Montplaisir J, Boucher S, Poirier G et al : Clinical, polysomnographic, and genetic characteristics of restless legs syndrome : a study of 133 patients diagnosed with new standard criteria. Mov Disord 12 (1) : 61-65, 1997.
PubMed
3) Pennestri MH, Montplaisir J, Colombo R et al : Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 68 (15) : 1213-1218, 2007.
PubMed
4) Allen RP, Picchietti DL, Garcia-Borreguero D et al : Restless legs syndrome/Willis-Ekbom disease diagnostic criteria : updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria?history, rationale, description, and significance. Sleep Med 15 (8) : 860-873, 2014.
 
5) Hening WA, Allen RP, Washburn M et al : The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics"). Sleep Med 10 (9) : 976-981, 2014.
 
6) Clemens S, Rye D, Hochman S : Restless legs syndrome : revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67 (1) : 125-130, 2006.
PubMed
7) Winkelmann J, Wetter TC, Collado-Seidel V et al : Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 23 (5) : 597-602, 2000.
 
8) Trenkwalder C, Allen R, Hogl B et al : Restless legs syndrome associated with major diseases : A systematic review and new concept. Neurology 86 (14) : 1336-1343, 2016.
 
9) Inoue Y, Oka Y, Kagimura T et al : Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting. Psychiatry Clin Neurosci 67 (6) : 412-419, 2013.
 
10) Walters AS, LeBrocq C, Dhar A et al : Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4 (2) : 121-132, 2003.
 
11) Silber MH, Richardson JW : Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 78 (1) : 52-54, 2003.
PubMed
12) Garcia-Borreguero D, Ferini-Strambi L, Kohnen R et al : European guidelines on management of restless legs syndrome : report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 19 (11) : 1385-1396, 2012.
 
13) Inoue Y, Kuroda K, Hirata K et al : Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome : randomized trial. Neuropsychobiology 63 (1) : 35-42, 2011.
PubMed
14) Zintzaras E, Kitsios GD, Papathanasiou AA et al : Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis. Clin Ther 32 (2) : 221-237, 2010.
PubMed
15) Inoue Y, Hirata K, Kuroda K et al : Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome : A polysomnographic randomized, double-blind, placebo-controlled study. Sleep Med 11 (1) : 11-16, 2010.
PubMed
16) Montplaisir J, Nicolas A, Denesle R et al : Restless legs syndrome improved by pramipexole : a double-blind randomized trial. Neurology 52 (5) : 938-943, 1999.
PubMed
17) Garcia-Borreguero D, Allen RP, Benes H et al : Augmentation as a treatment complication of restless legs syndrome : concept and management. Mov Disord 22 (Suppl 18) : S476-484, 2007.
 
18) Inoue Y, Hirata K, Hayashida K et al : Efficacy, safety and risk of augmentation of rotigotine for treating restless legs syndrome. Prog Neuropsychopharmacol Biol Psychiatry 40 : 326-333, 2013.
PubMed
19) Oertel W, Trenkwalder C, Benes H et al : Longterm safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome : a 5-year open-label extension study. Lancet Neurol 10 (8) : 710-720, 2011.
PubMed
20) Garcia-Borreguero D, Hogl B, Ferini-Strambi L et al : Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease) : results from a prospective, multicenter study over 66 weeks. Mov Disord 27 (2) : 277-283, 2012.
PubMed
21) Winkelman JW, Bogan RK, Schmidt MH et al : Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome. Mov Disord 26 (11) : 2065-2072, 2011.
PubMed
22) Garcia-Borreguero D, Larrosa O, de la Llave Y et al : Treatment of restless legs syndrome with gabapentin : a double-blind, cross-over study. Neurology 59 (10) : 1573-1579, 2002.
PubMed
23) Inoue Y, Uchimura N, Kuroda K et al : Longterm efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients. Prog Neuropsychopharmacol Biol Psychiatry 36 (2) : 251-257, 2012.
PubMed
24) Garcia-Borreguero D, Allen RP, Kohnen R et al : Diagnostic standards for dopaminergic augmentation of restless legs syndrome : report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 8 (5) : 520-530, 2007.
 
25) Allen RP, Ondo WG, Ball E et al : Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med 12 (5) : 431-439, 2011.
 
26) Silver N, Allen RP, Senerth J, Earley CJ : A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome. Sleep Med 12 (5) : 440-444, 2011.
PubMed
27) Takahashi M, Nishida S, Nakamura M et al : Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy : Rate and risk factors in a retrospective study. PloS one 12 (3) : e0173535, 2017.
 
28) Trenkwalder C, Hogl B, Benes H et al : Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 9 (5) : 572-574, 2008.
PubMed
29) Garcia-Borreguero D, Silber MH, Winkelman JW et al : Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation : a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med 21 : 1-11, 2016.
PubMed
P.1721 掲載の参考文献
1) Guilleminault C, Eldridge FL, Dement WC : Insomnia with sleep apnea : a new syndrome. Science 181 (4102) : 856-858, 1973.
PubMed
2) Tregear S, Reston J, Schoelles K et al : Obstructive sleep apnea and risk of motor vehicle crash ; systematic review and meta-analysis. J CIin Sleep Med 5 : 573-581, 2009.
 
3) Kushida CA, Nichols DA, Holmes TH, Quan SF et al : Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients : The Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep 35 : 1593-1602, 2012.
 
4) Inoue A, Chiba S, Matsuura K, Osafune H et al : Nasal function and CPAP compliance. Auris Nasus Larynx 46 (4) : 548-558, 2019.
PubMed
5) 村瀬公彦, 谷澤公伸, 津田徹他 : 遠隔モニタリングシステムを用いたCPAP療法および在宅酸素療法の対面診療間隔の検討. 平成29年度 厚生労働科学研究費補助金 (地域医療基盤開発推進研究事業) 研究報告書 : 47-59, 2018.
 
6) Karine S, Esra T, Plamen P et al : Brief communication : Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Med 141 : 846-851, 2004.
 
7) Peppard PE, Young T, Palta M, Dempsey J et al : Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284 : 3015-3021, 2000.
PubMed
8) Bignold JJ, Deans-Costi G, Goldsworthy MR et al : Poor long-term patient compliance with the tennis ball technique for treating positional obstructive sleep apnea. J Clin Sleep Med 5 : 428-430, 2009.
PubMed
9) Oksenberg A, Silverberg DS : The effect of body posture on sleep-related breathing disorders : facts and therapeutic implications. Sleep Med Rev 2 : 139-162, 1998.
PubMed
10) Camacho M, Certal V, Abdullatif J et al : Myofunctional therapy to treat obstructive sleep apnea : a systematic review and meta-analysis. Sleep 38 (5) : 669-675, 2015.
PubMed
11) Guilleminault C, Huang YS, Monteyrol PJ et al : Critical role of myofascial reeducation in pediatric sleep-disordered breathing. Sleep Med 14 : 518-525, 2013.
PubMed
12) Liu SY, Wayne Riley R, Pogrel A et al : Sleep Surgery in the Era of Precision Medicine. Atlas Oral Maxillofacial Surg Clin N Am 27 : 1-5, 2019.
 
13) Wellman A, Edwards BA, Sands SA et al : A simplified method for determining phenotypic traits in patients with OSA. J Appl Physiol 114 : 911-922, 2013.
 
14) Fujita S, Conway W, Zorick F et al : Surgical correction of anatomical abnormalities in obstructive sleep apnoea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 89 (6) : 923-934, 1981.
 
15) Vicini C, Hendawy E, Campanini A et al : Barbed Reposition Pharyngoplasty (BRP) for OSAHS : a feasibility, safety, efficacy and teachability pilot study. Eur Arch Otorhinolaryngol 272 (10) : 3065-3070, 2015.
PubMed
16) Strollo PJ, Soose RJ, Maurer JT et al : Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 370 : 139-149, 2014.
PubMed
17) Zaghi S, Holty JE, Certal V et al : Maxillomandibular advancement for treatment of obstructive sleep apnea : a meta-analysis. JAMA Otolaryngol. Head Neck Surg 142 (1) : 58-66, 2016.
PubMed
18) 佐々木章 : 肥満・糖尿病に対する外科治療の効果と今後の展望. 岩手医誌 70 (6) : 189-196, 2019.
 
19) Kamami Y-V : Outpatient treatment of sleep apnea syndrome with CO2 laser, LAW laser-assisted UPPP results on 46 patients. J Clin Laser Med Surg 12 (4) : 215-219, 1994.
 
20) Camacho M, Nesbitt NB, Lambert E et al : Laser-assisted Uvulopalatoplasty for Obstructive Sleep Apnea : A Systematic Review and Meta-Analysis. Sleep 40 : 1-8, 2017.
 
21) 外木守雄, 中島庸也, 佐藤一道他 : 睡眠時無呼吸症候群に対する歯科の役割. 耳展 55 (3) : 189-198, 2012.
 
22) 有坂岳大, 田賀仁, 外木守雄 : 閉塞性睡眠時無呼吸を歯科医師としてどう診るか? ～そのイビキ, 歯科で治るかも知れません! ～. 日本歯科医師会雑誌 69 (12) : 33-40, 2017.
 
P.1729 掲載の参考文献
1) 米国睡眠医学会 : V. 睡眠時随伴症群, 日本睡眠学会診断分類委員会訳, 睡眠障害国際分類 第3版 International Classification of Sleep Disorders, Third Edition, pp.165-210, ライフ・サイエンス, 東京, 2018.
 
2) Sastre JP, Jouvet M : [Oneiric behavior in cats]. Physiol Behav 22 (5) : 979-989, 1979.
PubMed
3) 菱川泰夫, 杉田義郎, 飯島壽佐美 他 : 異常な睡眠状態 "Stage 1-REM" とそれに類似したREM睡眠の解離現象の病態生理-幻覚・異常行動・意識障害を特徴とするせん妄状態のメカニズム. 神経進歩 25 (5) : 1129-1147, 1981.
 
4) Schenck CH, Bundlie SR, Ettinger MG et al : Chronic behavioral disorders of human REM sleep : a new category of parasomnia. Sleep 9 (2) : 293-308, 1986.
PubMed
5) 宮本雅之, 宮本智之 : レム睡眠行動異常症と神経変性疾患. 日本医事新報 4415 : 57-64, 2008.
Medical*Online
6) Haba-Rubio J, Frauscher B, Marques-Vidal P et al : Prevalence and Determinants of REM Sleep Behavior Disorder in the General Population. Sleep. 2018 Feb 1 ; 41 (2). pii : zsx197. doi : 10.1093/sleep/zsx197.
 
7) Uchiyama M, Isse K, Tanaka K et al : Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 45 (4) : 709-712, 1995.
 
8) Iranzo A, Tolosa E, Gelpi E et al : Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder : an observational cohort study. Lancet Neurol 12 (5) : 443-453, 2013.
PubMed
9) Boeve BF, Silber MH, Ferman TJ et al : Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med 14 (8) : 754-762, 2013.
PubMed
10) Ferini-Strambi L, Di Gioia MR, Castronovo V et al : Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD) Does the idiopathic form of RBD really exist? Neurology 62 : 41-45, 2004.
PubMed
11) Miyamoto T, Miyamoto M, Inoue Y et al : Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology 67 (12) : 2236-2238, 2006.
PubMed
12) Berg D, Postuma RB, Adler CH et al : MDS research criteria for prodromal Parkinson's disease. Mov Disord 30 (12) : 1600-1611, 2015.
PubMed
13) Miyamoto M, Miyamoto T, Iwanami M et al : Preclinical substantia nigra dysfunction in rapid eye movement sleep behavior disorder. Sleep Med 13 (1) : 102-106, 2012.
PubMed
14) Schenck CH, Bundlie SR, Mahowald MW : Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46 (2) : 388-393, 1996. Erratum in : Neurology 46 (6) : 1787, 1996.
 
15) Schenck CH, Boeve BF, Mahowald MW : Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder : a 16-year update on a previously reported series. Sleep Med 14 (8) : 744-748, 2013.
PubMed
16) Postuma RB, Gagnon JF, Vendette M et al : Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72 (15) : 1296-1300, 2009.
PubMed
17) Iranzo A, Fernandez-Arcos A, Tolosa E et al : Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder : study in 174 patients. PLoS One. 2014 Feb 26 ; 9 (2) : e89741. doi : 10.1371/journal.pone.0089741. eCollection 2014.
 
18) Miyamoto T, Miyamoto M : Phenoconversion from Idiopathic Rapid Eye Movement Sleep Behavior Disorder to Lewy Body Disease. Mov Disord Clin Pract 5 (5) : 506-511, 2018.
PubMed
19) Galbiati A, Verga L, Giora E et al : The risk of neurodegeneration in REM sleep behavior disorder : A systematic review and meta-analysis of longitudinal studies. Sleep Med Rev 43 : 37-46, 2019.
PubMed
20) Postuma RB, Iranzo A, Hu M et al : Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder : a multicentre study. Brain 142 (3) : 744-759, 2019.
PubMed
21) Iranzo A, Stefani A, Serradell M et al : SINBAR (Sleep Innsbruck Barcelona) group. Characterization of patients with longstanding idiopathic REM sleep behavior disorder. Neurology 89 (3) : 242-248, 2017.
PubMed
22) Stiasny-Kolster K, Mayer G, Schafer S et al : The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord 22 (16) : 2386-2393, 2007.
PubMed
23) Miyamoto T, Miyamoto M, Iwanami M et al : The REM sleep behavior disorder screening questionnaire : validation study of a Japanese version. Sleep Med 10 (10) : 1151-1154, 2009.
PubMed
24) 米国睡眠医学会 : 日本睡眠学会監訳, AASMによる睡眠および随伴イベントの判定マニュアル ルール, 用語, 技術仕様の詳細 Version 2.5, pp.49-55, ライフ・サイエンス, 東京, 2018.
 
25) Frauscher B, Iranzo A, Gaig C et al : SINBAR (Sleep Innsbruck Barcelona) Group. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep 35 (6) : 835-847, 2012.
PubMed
26) Iranzo A, Ratti PL, Casanova-Molla J et al : Excessive muscle activity increases over time in idiopathic REM sleep behavior disorder. Sleep 32 (9) : 1149-1153, 2009.
PubMed
27) Postuma RB, Gagnon JF, Rompre S et al : Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology 74 (3) : 239-244, 2010.
PubMed
28) Sasai-Sakuma T, Frauscher B, Mitterling T et al : Quantitative assessment of isolated rapid eye movement (REM) sleep without atonia without clinical REM sleep behavior disorder : clinical and research implications. Sleep Med 15 (9) : 1009-1015, 2014.
PubMed
29) Stefani A, Gabelia D, Hogl B et al : Long-Term Follow-up Investigation of Isolated Rapid Eye Movement Sleep Without Atonia Without Rapid Eye Movement Sleep Behavior Disorder : A Pilot Study. J Clin Sleep Med 11 (11) : 1273-1279, 2015.
PubMed
30) Hogl B, Stefani A, Videnovic A : Idiopathic REM sleep behaviour disorder and neurodegeneration-an update. Nat Rev Neurol 14 (1) : 40-55. 2018.
PubMed
31) Sixel-Doring F, Trautmann E, Mollenhauer B et al : Rapid eye movement sleep behavioral events : a new marker for neurodegeneration in early Parkinson disease? Sleep 37 (3) : 431-438, 2014.
PubMed
32) Sixel-Doring F, Zimmermann J, Wegener A et al : The Evolution of REM Sleep Behavior Disorder in Early Parkinson Disease. Sleep 39 (9) : 1737-1742, 2016.
PubMed
33) Aurora RN, Zak RS, Maganti RK et al : Standards of Practice Committee ; American Academy of Sleep Medicine. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 6 (1) : 85-95, 2010. Erratum in : J Clin Sleep Med 6 (2), 2010 : table of contents.
 
34) Schenck CH, Montplaisir JY, Frauscher B et al : Rapid eye movement sleep behavior disorder : devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med 14 (8) : 795-806, 2013.
 
35) St Louis EK, Boeve BF : REM Sleep Behavior Disorder : Diagnosis, Clinical Implications, and Future Directions. Mayo Clin Proc 92 (11) : 1723-1736, 2017.
PubMed
36) Hogl B, Santamaria J, Iranzo A et al : Precision Medicine in Rapid Eye Movement Sleep Behavior Disorder. Sleep Med Clin 14 (3) : 351-362, 2019.
PubMed
P.1735 掲載の参考文献
1) International classification of sleep disorders, 3rd edition (ICSD-3). American Academy of Sleep Medicine, Darien, 2014.
 
2) Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V), American Psychiatric Association, Washington D.C., 2013.
 
3) Jones CR, Campbell SS, Zone SE et al : Familial advanced sleep-phase syndrome : A short-period circadian rhythm variant in humans. Nat Med 5 : 1062-1065, 1999.
 
4) Toh KL, Jones CR, He Y et al : An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291 : 1040-1043, 2001.
PubMed
5) Xu Y, Padiath QS, Shapiro RE et al : Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 434 : 640-644, 2005.
PubMed
6) Satoh K, Mishima K, Inoue Y et al : Two pedigrees of familial advanced sleep phase syndrome in Japan. SLEEP 26 : 416-417, 2003.
PubMed
7) Ebisawa T, Uchiyama M, Kajimura N et al : Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep 2 : 342-346, 2001.
PubMed
8) Hida A, Kitamura S, Katayose Y et al : Screening of clock gene polymorphisms demonstrates association of a PER3 polymorphism with morningness-eveningness preference and circadian rhythm sleep disorder. Sci Rep 4 : 6309, 2014.
PubMed
9) Abe T, Inoue Y, Komada Y et al : Relation between morningness-eveningness score and depressive symptoms among patients with delayed sleep phase syndrome. Sleep Med 12 : 680-684, 2011.
PubMed
10) Khalsa SB, Jewett ME, Cajochen C et al : A phase response curve to single bright light pulses in human subjects. J Physiol 549 : 945-952, 2003.
PubMed
11) Lewy AJ and Sack RL : Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans : a brief review and critique of the literature, J Biol Rhythms 12 : 588-594, 1997.
PubMed
12) Burgess HJ, Revell VL, Eastman CI : A three pulse phase response curve to three milligrams of melatonin in humans. J Physiol 586 : 639-647, 2008.
PubMed
P.1744 掲載の参考文献
1) Plazzi G, Pizza F, Palaia V et al : Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 134 : 3480-3492, 2011.
 
2) Vandi S, Pizza F1, Antelmi E et al : A standardized test to document cataplexy. Sleep Med 53 : 197-204, 2019.
 
3) 西山詮, 本多裕, 鈴木二郎他 : ナルコレプシーの治療経過中に生じた幻覚症について. 精神医学 8 : 49-55, 1966.
 
4) Ponziani V, Gennari M, Pizza F et al : Growing Up with Type 1 Narcolepsy : Its Anthropometric and Endocrine Features. J Clin Sleep Med 12 : 1649-1657, 2016.
PubMed
5) 本多真 : ナルコレプシーの代謝. 睡眠医療 13 : 179, 2019.
Medical*Online
6) Fronczek R, Overeem S, Lammers GJ et al : Altered skin-temperature regulation in narcolepsy relates to sleep propensity. Sleep 29 : 1444-1449, 2006.
PubMed
7) Littner MR, Kushida C, Wise M et al : Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28 : 113-121, 2005.
PubMed
8) Mignot E, Lammers GJ, Ripley B et al : The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59 : 1553-1562, 2002.
PubMed
9) American Academy of Sleep Medicine : International classification of sleep disorders, 3rd ed, American Academy of Sleep Medicine, Darien, 2014.
 
10) Han F, Lin L, Schormair B et al : HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep 37 : 1601-1608, 2014.
PubMed
11) 高橋康郎 : ナルコレプシーと逆説睡眠. 最新医学 26 : 98-105, 1971.
 
12) Saper CB, Scammell TE, Lu J : Hypothalamic regulation of sleep and circadian rhythms. Nature 437 : 1257-1263, 2005.
PubMed
13) Mochizuki T, Crocker A, McCormack S et al : Behavioral state instability in orexin knock-out mice. J Neurosci 24 6291-6300, 2004.
PubMed
14) Mignot E : Genetic and familial aspects of narcolepsy. Neurology 50 : S16-22, 1998.
PubMed
15) Mignot E, Lin L, Rogers W et al : Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68 : 686-699, 2001.
PubMed
16) Mignot E, Lin L, Finn L et al : Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 129 : 1609-1623, 2006.
PubMed
17) Goel N, Banks S, Mignot E : DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue. Neurology 75 : 1509-1519, 2010.
PubMed
18) Hallmayer J, Faraco J, Lin L et al : Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 41 : 708-711, 2009.
 
19) Han F, Lin L, Li J et al : TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy. Sleep Med 13 : 269-272, 2012.
 
20) Faraco J, Lin L, Kornum BR et al : ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy. PLoS Genet 9 : e1003270, 2013.
 
21) Kornum BR, Kawashima M, Faraco J et al : Common variants in P2RY11 are associated with narcolepsy. Nat Genet 43 : 66-71, 2011.
PubMed
22) Toyoda H, Miyagawa T, Koike A et al : A polymorphism in CCR1/CCR3 is associated with narcolepsy. Brain Behav Immun 49 : 148-155, 2015.
PubMed
23) Toyoda H, Honda Y, Tanaka S et al : Narcolepsy susceptibility gene CCR3 modulates sleep-wake patterns in mice. PLoS One 12 : e0187888, 2017.
PubMed
24) Tanaka S, Honda M : IgG abnormality in narcolepsy and idiopathic hypersomnia. PLoS One 5 : e9555, 2010.
PubMed
25) Mahoney CE, Cogswell A, Koralnik IJ : The neurobiological basis of narcolepsy. Nat Rev Neurosci 20 : 83-93, 2019.
PubMed
26) Peyron C, Faraco J, Rogers W et al : A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6 : 991-997, 2000.
 
27) Thannickal TC, Moore RY, Nienhuis R et al : Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 : 469-474, 2000.
PubMed
28) Honda M, Arai T, Fukazawa M et al. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy. Neurology 73 : 511-517, 2009.
PubMed
29) 本多真 : ナルコレプシーの自己免疫仮説. 日本臨牀 71 (増刊号 5) : 711-717, 2013.
 
30) Latorre D, Kallweit U, Armentani E et al : T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562 : 63-68, 2018.
PubMed
31) Pedersen NW, Holm A, Kristensen NP et al : CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat Commun 10 : 837, 2019.
PubMed
32) Miyagawa T, Kawashima M, Nishida N et al : Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 40 : 1324-1328, 2008.
PubMed
33) Miyagawa T, Kawamura H, Obuchi M et al : Effects of oral L-carnitine administration in narcolepsy patients : a randomized, double-blind, crossover and placebo-controlled trial. PLoS One 8 : e53707, 2013.
 
34) Koepsell TD, Longstreth WT, Ton TG : Medical exposures in youth and the frequency of narcolepsy with cataplexy : a population-based case-control study in genetically predisposed people. J Sleep Res 19 : 80-86, 2010.
 
35) Aran A, Lin L, Nevsimalova S et al : Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32 : 979-983, 2009.
PubMed
36) Nohynek H, Jokinen J, Partinen M et al : AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 7 : e33536, 2012.
PubMed
37) Partinen M, Saarenpaa-Heikkila O, Ilveskoski I et al : Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 7 : e33723, 2012.
 
38) Han F, Lin L, Warby SC et al : Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70 : 410-417, 2011.
PubMed
39) 神山潤 : 朝起きられない人のねむり学, 新曜社, 東京, 2016.
 
40) 本多真 : なるこ会におけるピアサポートの実践とその効果. 精神科 31 : 564-567, 2017.
 
41) Thorpy M : Therapeutic advances in narcolepsy. Sleep Med 8 : 427-440, 2007.
PubMed

【臨床試験】

P.1767 掲載の参考文献
1) グラクソ・スミスクライン株式会社 : エプジコム(R) 配合錠 医薬品インタビューフォーム
 
2) 後発医薬品の生物学的同等性試験ガイドラインについて (平成9年12月22日付医薬審第487号)
 
3) 後発医薬品の生物学的同等性試験ガイドライン等の一部改正について (平成24年2月29日薬食審査発0229 第10号)
 
4) 医薬品の臨床試験の実施の基準に関する省令 (平成9年3月27日付厚生省令第28号)
 
5) 医薬品の臨床試験の実施の基準に関する省令の一部を改正する省令 (平成28年1月22日付厚生労働省令第9号), 医薬品の臨床試験の実施の基準に関する省令の一部を改正する省令の施行について (平成28年1月22日付薬生発0122 第2号)
 

【Diagnosis】

P.1780 掲載の参考文献
1) Serada S et al : iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann Rheum Dis 69 (4) : 770-774, 2010.
PubMed
2) Serada S et al : Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflamm Bowel Dis 18 (11) : 2169-2179, 2012.
PubMed
3) Shinzaki S et al : Leucine-rich alpha-2 glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis. JCC 11 (1) : 84-91, 2017.
PubMed
4) Neurath MF, Travis SP : Mucosal healing in inflammatory bowel diseases : a systematic review. Gut 61 (11) : 1619-1635, 2012.
PubMed
5) Froslie KF et al : Mucosal healing in inflammatory bowel disease : results from a Norwegian population-based cohort. Gastroenterology 133 (2) : 412-422, 2007.
PubMed
6) Vermeire S et al : C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis 10 (5) : 661-665, 2004.
PubMed
P.1790 掲載の参考文献
1) Hall CB, Weinberg GA, Iwane MK et al : The burden of respiratory syncytial virus infection in young children. N Engl J Med 360 (6) : 588-598, 2009.
PubMed
2) Hall CB, Weinberg GA, Blumkin AK et al : Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pedi atrics 132 (2) : e341-348, 2013.
 
3) 河合直樹, 池松秀之, 岩城紀男他 : PCRによる高齢者を含めたRSウイルス検出例の検討-新しい迅速診断キットの試用経験を含めて-. 感染症学雑誌 82 : 1-5, 2008.
 
4) Doi I, Nagata N, Tsukagoshi H et al : An outbreak of acute respiratory infections due to human respiratory syncytial virus in a nursing home for the elderly in Ibaraki, Japan, 2014. Jpn J Infect Dis 67 (4) : 326-328, 2014.
 
5) Kurai D, Sasaki Y, Saraya T et al : Pathogen profiles and molecular epidemiology of respiratory viruses in Japanese inpatients with community-acquired pneumonia. Respir Investig 54 (4) : 255-263, 2016.
PubMed
6) 国立感染症研究所 : RSウイルス感染症 2014年1月～2018年9月. 病原微生物検出情報 (IASR) 39 (12) : 207-221, 2018.
 
7) 横井一, 田中俊光, 水村綾乃他 : Real-time RT-PCR法によるRSウイルス遺伝子の検出とサブグループ型別. 感染症誌 86 : 569-576, 2012.
 
8) 菖蒲川由郷 : RSウイルス感染症-夏の流行が起きる気象条件. 小児科 59 (4) : 363-368, 2018.
 
9) 成高中之, 鈴木光幸, 齋藤暢知他 : インフルエンザ・RSV同時検出迅速検査キットを用いたRSV感染症の鑑別と臨床像の検討. 外来小児科 16 (1) : 76-78, 2013.
Medical*Online
10) 日本小児呼吸器学会・日本小児感染症学会 : 小児呼吸器感染症診療ガイドライン 2017. 小児呼吸器感染症診療ガイドライン作成委員会, 尾内一信, 岡田賢司, 黒崎知道監, 協和企画, 東京, 2016.
 
11) 厚生労働省 : 保育所における感染症対策ガイドライン (2018年改訂版). https://www.mhlw.go.jp/file/06-Seisakujouhou-11900000-Koyoukintoujidoukateikyoku/0000201596.pdf
 
12) Lee N, Lui GC, Wong KT et al : High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 57 (8) : 1069-1077, 2013.
PubMed
13) Matias G, Taylor R, Haguinet F et al : Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status. BMC Public Health 17 (1) : 271, 2017.
PubMed
14) 時田章史 : 抗原迅速診断検査の医療経済学的思考. 小児内科 47 (5) : 758-761, 2015.
 
15) 時田章史 : 感染症迅速診断キットを最大限に活用する為のポイント. 医学と薬学 72 (11) : 1919-1928, 2015.
Medical*Online
P.1793 掲載の参考文献
1) 日本環境感染学会 : 環境感染誌 29 (Suppl. III) : 2014.
 
2) 国立感染症研究所 https://www.niid.go.jp/niid/ja/diseases/ha/rubella.html
 
P.1808 掲載の参考文献
1) 瀬戸山陽子他 : 非ホジキン悪性リンパ腫における血清可溶性IL-2レセプターα鎖値測定の有用性. 臨床病理 42 : 834-842, 1994.
 
2) 増田亜希子 : 可溶性IL-2Rレセプター. medicina 52 (4) 増刊号 : 150-151, 2015.
 
3) 岸野好純, 上硲俊法 : 免疫測定法による血中微量成分の検査 ; 感染症, 腫瘍マーカー, ホルモンの検査について. 近畿大医誌 (Med J Kindai Univ) 34 (1) : 75-82, 2009.
 
P.1818 掲載の参考文献
1) Kato H, Torigoe T : Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40 (4) : 1621-1628, 1977.
PubMed
2) 縄田修吾, 加藤紘, 中村和行 : SCC腫瘍マーカーの発現とその機能解析. Jpn J Electroph 42 : 257-263, 1998.
 
3) de Bruijn HW, Duk JM, van der Zee AG et al : The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumour Biol 19 (6) : 505-516, 1998.
 
4) Snyderman CH, D'Amico F, Wagner R et al : A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Arch Otolaryngol Head Neck Surg 121 (11) : 1294-1297, 1995.
 
5) Vassilakopoulos T, Troupis T, Sotiropoulou C et al : Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer. Lung Cancer 32 (2) : 137-144, 2001.
PubMed
6) 加藤紘 : SCC抗原. 日本臨牀 48 : 1057-1059, 1997.
 
7) Passing H, Bablok : A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 21 (11) : 709-720, 1983.
 
8) 渡邉万里子, 清宮正徳, 大山里子他 : エクルーシス試薬SCCを用いたSCC抗原測定の検討. 医学と薬学 74 (2) : 181-188, 2017.
Medical*Online
9) 阿部正樹, 八木道隆, 鈴木晴美 : 異なる2種のSCC測定試薬における測定値の比較検討-扁平上皮癌におけるSCCA-1, SCCA-2抗原量との関連性を中心に-. JJCLA 44 (3) : 224-230, 2019.
 
10) 堀田大輔, 今野良 : エクルーシス試薬SCCの基礎的検討および臨床性能評価. 医学と薬学 74 (8) : 933-943, 2017.
Medical*Online
P.1826 掲載の参考文献
1) 猿田享男 : アルドステロン. 日本臨床 63 (増刊号 8) : 328-331, 2005.
 
2) Nishikawa T, Omura M, Satoh F et al : Guidelines for the diagnosis and treatment of primary aldosteronism-The Japan Endocrine Society 2009-. Endocr J 58 : 711-721, 2011.
PubMed
3) Nishikawa T, Omura M, Kawaguchi M et al : Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood. Endocr J 63 : 1065-1080, 2016.
PubMed
4) Nishizono I, Iida S, Suzuki N et al : Rapid and Sensitive Chemiluminescent Enzyme Immunoassay for Measuring Tumor Markers. Clin Chem 37 : 1639-1644, 1991.
PubMed
5) 日本内分泌学会, 日本内分泌外科学会, 日本高血圧学会 : わが国の原発性アルドステロン症の診療に関するコンセンサスステートメント. 診断と治療社, 東京, 2016.
 
6) Funder JW et al : The Management of Primary Aldosteronism : Case Detection, Diagnosis, and Treatment : An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101 : 1889-1916, 2016.
PubMed
P.1832 掲載の参考文献
1) 沖隆他 : レニンIRMAキット (D-4102) の臨床的有用性について. ホルモンと臨床 42 (11) : 1091-1094, 1994.
 
2) 成瀬清子他 : 直接ラジオイムノアッセイ法を用いた各種疾患における血中レニン濃度測定の臨床的意義. ホルモンと臨床 36 (1) : 91-95, 1988.
 
3) Nishizono I, Iida S, Suzuki N et al : Rapid and Sensitive Chemiluminescent Enzyme Immunoassay for Measuring Tumor Markers. Clin Chem 37 : 1639-1644, 1991.
PubMed
4) Nishikawa T, Omura M, Satoh F et al : Guidelines for the diagnosis and treatment of primary aldosteronism-The Japan Endocrine Society 2009-. Endocr J 58 : 711-721, 2011.
PubMed
5) Funder JW et al : The Management of Primary Aldosteronism : Case Detection, Diagnosis, and Treatment : An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101 : 1889-1916, 2016.
PubMed
P.1843 掲載の参考文献
1) 坂井優子 : インフルエンザ迅速診断キットの性能について. インフルエンザ 17 (2) : 43-50, 2016.
 
2) 原三千丸 : A型インフルエンザに対する3種類のイムノクロマト法迅速診断キットの比較検討. 感染症学雑誌 78 (11) : 935-942, 2004.
 
3) 日本自動化学会第3回POCセミナー実行委員会 : インフルエンザウイルス抗原検査-検査精度と信頼性-. 機器・試薬 28 (6) : 1-7, 2005.
 
4) 市川正孝 : 判定時間を短縮した新しいインフルエンザ迅速診断キット「クイックナビTM-Flu2」の評価. 医学と薬学 74 (10) : 1299-1310, 2017.
 
5) 池松秀之 : 新しいインフルエンザウイルス抗原検出 (迅速診断) キット「ブライトポック(R) Flu・Neo」の陽性判定時間と発症早期での検出能. 医学と薬学 75 (7) : 823-832, 2018.
Medical*Online
6) 池松秀之 : 新しいインフルエンザウイルス抗原検出 (迅速診断) キット「スタットマーク(TM) FLUスティック II」の鼻腔ぬぐい液, 鼻腔吸引液および鼻汁鼻かみ液での性能と陽性判定時間の検討. 医学と薬学 76 (3) : 375-385, 2019.
Medical*Online
7) 三田村敬子 : インフルエンザウイルス抗原検出試薬 「ラピッドテスタ(R) FLUスティックsp」の臨床評価. 医学と薬学 76 (6) : 887-896, 2019.
Medical*Online
8) 国立感染症研究所 : 今冬のインフルエンザについて (2018/19シーズン) https://www.niid.go.jp/niid/ja/flu-m/590-idsc/8979-fludoko-2018.html
 

【Health Care】

P.1850 掲載の参考文献
1) 患者調査. 厚生労働省, 平成29年.
Medical*Online
2) 国民生活基礎調査. 厚生労働省, 平成28年.
Medical*Online
3) 厚生科学審議会地域保健健康増進栄養部会, 次期国民健康づくり運動プラン策定専門委員会 : 健康日本 21 (第2次) の推進に関する参考資料. 平成24年. https://www.mhlw.go.jp/bunya/kenkou/dl/kenkounippon21_02.pdf 〔最終アクセス 2019年10月25日〕
 
4) 北畠義典, 種田行雄, 永松俊哉他 : 高齢者における膝関節進展筋力と生活体力の起居能力および歩行能力との関係. 体力研究 102 : 7-14, 2004.
 
5) 後藤康夫, 村成幸, 松田雅彦他 : 高齢者の肩関節障害の疫学調査. 肩関節 20 (1) : 205-208, 1996.
 
6) 岩谷力, 白木原憲明, 飛松好子 : 地域在住高齢者における腰廃部痛が運動・生活機能に及ぼす影響. 日本腰痛会誌 11 (1) : 27-34. 2005.
 
7) 田口孝行, 柳澤健 : 高齢女性の日常生活活動に対する自己効力感に関連する要因の分析 : 運動機能と痛みの観点から. 日本保健科学学会誌 10 (3) : 182-190, 2007.
Medical*Online
8) 介護予防にかかる総合的な調査研究事業報告書. 財団法人日本公衆衛生協会. 平成22年. www.jpha.or.jp/sub/pdf/menu04_5_04_all.pdf〔最終アクセス 2019年10月25日〕
 
9) 腰痛に関する全国調査報告書. 日本整形外科学会, 2007. https://www.joa.or.jp/media/comment/pdf/lumbaxgo_report_030731.pdf 〔最終アクセス 2019年10月25日〕
 
10) 健康保険ガイド. 全国健康保険協会. https://www.kyoukaikenpo.or.jp/g3/cat310/sb3070/r141〔最終アクセス 2019年10月25日〕
 

書評

最近チェックした商品履歴

Loading...